BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15890923)

  • 1. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.
    Patterson NA; Smith JL; Ozbun MA
    J Virol; 2005 Jun; 79(11):6838-47. PubMed ID: 15890923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.
    Ozbun MA
    J Virol; 2002 Nov; 76(22):11291-300. PubMed ID: 12388689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line.
    Ozbun MA
    J Gen Virol; 2002 Nov; 83(Pt 11):2753-2763. PubMed ID: 12388811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.
    Combita AL; Touzé A; Bousarghin L; Sizaret PY; Muñoz N; Coursaget P
    FEMS Microbiol Lett; 2001 Oct; 204(1):183-8. PubMed ID: 11682199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry.
    Drobni P; Mistry N; McMillan N; Evander M
    Virology; 2003 May; 310(1):163-72. PubMed ID: 12788640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor.
    Culp TD; Budgeon LR; Christensen ND
    Virology; 2006 Mar; 347(1):147-59. PubMed ID: 16376962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infection requires cell surface heparan sulfate.
    Giroglou T; Florin L; Schäfer F; Streeck RE; Sapp M
    J Virol; 2001 Feb; 75(3):1565-70. PubMed ID: 11152531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.
    Shafti-Keramat S; Handisurya A; Kriehuber E; Meneguzzi G; Slupetzky K; Kirnbauer R
    J Virol; 2003 Dec; 77(24):13125-35. PubMed ID: 14645569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4.
    Sibbet G; Romero-Graillet C; Meneguzzi G; Campo MS
    J Gen Virol; 2000 Feb; 81(Pt 2):327-34. PubMed ID: 10644830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
    Selinka HC; Florin L; Patel HD; Freitag K; Schmidtke M; Makarov VA; Sapp M
    J Virol; 2007 Oct; 81(20):10970-80. PubMed ID: 17686860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line.
    Flores ER; Allen-Hoffmann BL; Lee D; Sattler CA; Lambert PF
    Virology; 1999 Sep; 262(2):344-54. PubMed ID: 10502513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrageenan is a potent inhibitor of papillomavirus infection.
    Buck CB; Thompson CD; Roberts JN; Müller M; Lowy DR; Schiller JT
    PLoS Pathog; 2006 Jul; 2(7):e69. PubMed ID: 16839203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.
    Culp TD; Budgeon LR; Marinkovich MP; Meneguzzi G; Christensen ND
    J Virol; 2006 Sep; 80(18):8940-50. PubMed ID: 16940506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes.
    Wang HK; Wei Q; Moldoveanu Z; Huh WK; Vu HL; Broker TR; Mestecky J; Chow LT
    Vaccine; 2016 Jun; 34(27):3171-3177. PubMed ID: 27113165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.
    Smith JL; Campos SK; Ozbun MA
    J Virol; 2007 Sep; 81(18):9922-31. PubMed ID: 17626097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes.
    Thomas JT; Oh ST; Terhune SS; Laimins LA
    J Virol; 2001 Aug; 75(16):7564-71. PubMed ID: 11462028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection.
    Surviladze Z; Sterkand RT; Ozbun MA
    J Gen Virol; 2015 Aug; 96(8):2232-2241. PubMed ID: 26289843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose.
    Wilson R; Laimins LA
    Methods Mol Med; 2005; 119():157-69. PubMed ID: 16350403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that papillomavirus capsids exist in two distinct conformations.
    Selinka HC; Giroglou T; Nowak T; Christensen ND; Sapp M
    J Virol; 2003 Dec; 77(24):12961-7. PubMed ID: 14645552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.